Citadel Advisors
AIFF

Citadel Advisors’s Firefly Neuroscience AIFF Stock Holding History

Citadel Advisors’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-70
Closed -$1.01K – 15659
2022
Q4 		$1.01K Buy
+70
New +$1.63K ﹤0.01% 14544

Other funds holding AIFF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors's AIFF Position: Q1 2025 in Review

Citadel Advisors sold out of Firefly Neuroscience (AIFF) in Q1 2025, closing a stake of 11,334 shares — an estimated $30K sold.

Citadel Advisors first reported a position in AIFF in Q2 2022 and held it in 3 quarters. The position peaked at $39K in Q2 2022. 19 funds tracked by Wall St. Rank hold AIFF as of Q1 2025.

  • Citadel Advisors reported no remaining Firefly Neuroscience position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 11,334 Firefly Neuroscience shares in Q1 2025, an estimated $30K.
  • Citadel Advisors first reported a position in Firefly Neuroscience in Q2 2022 and held it in 3 quarters.
  • Citadel Advisors's Firefly Neuroscience position peaked at $39K in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.